Nanoengineered STING Agonists Must Balance Timing and Location for Cancer Immunotherapy
A review highlights how nanoengineering can control the timing, cellular targeting, and safety of STING agonists to overcome clinical limitations ...
A review highlights how nanoengineering can control the timing, cellular targeting, and safety of STING agonists to overcome clinical limitations ...
Tumour-intrinsic STING activation in breast cancer correlates with longer patient survival, delayed brain metastasis development, and coordinated cellular proteomic reprogramming.
Intratumoral injections of STING agonists reduced tumor volumes in four dogs with advanced sarcomas, enabling successful surgical resection in two ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.